You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-EGFR-EGFR inhibitor 9
EGFR inhibitor 9

Chemical Structure : EGFR inhibitor 9

CAS No.:

EGFR inhibitor 9

Catalog No.: PC-21316Not For Human Use, Lab Use Only.

EGFR inhibitor 9 is a potent, selective, brain-penetrant and orally bioavailable EGFR inhibitor, exhibits potent activity in osimertinib-resistant cell lines bearing L858R/C797S and exon19del/C797S EGFR resistance mutations.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

EGFR inhibitor 9 is a potent, selective, brain-penetrant and orally bioavailable EGFR inhibitor, exhibits potent activity in osimertinib-resistant cell lines bearing L858R/C797S and exon19del/C797S EGFR resistance mutations.
EGFR inhibitor 9 displays potent antiproliferative activity in patient-derived non-small-cell lung cancer cell lines HCC827 (EGFR mutation = exon19del), NCI-H3255 (EGFR mutation = L858R), and osimertinib-resistant engineered cell lines (Ba/F3-L858R/C797S; Ba/F3 del E746_A750/C797S) while displaying no activity in NCI-H1975 (EGFR mutation = L858R/T790M) and minimal activity in A431 cell line (overexpressed EGFRwt).
EGFR inhibitor 9 d isplays excellent activity against the NCI-H3255 NSCLC cell line bearing the common EGFRL858R mutation, with an IC50 of 7.2 nM.
EGFR inhibitor 9 also has potent activity against HCC827 NSCLC cells harboring EGFRdel E746_A750 with an IC50 of 3.1 nM.
EGFR inhibitor 9 exhibits strong activity in osimertinib-resistant engineered Ba/F3 cell lines bearing EGFRL858R/C797S and EGFRdel E746_A750/C797S.

Physicochemical Properties

M.Wt 461.92
Formula C22H25ClFN5O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-(3-chloro-2-fluorophenyl)-7-methoxy-6-(2-((4-methylpiperazin-1-yl)oxy)ethoxy)quinazolin-4-amine

References

1. Hill J, et al. J Med Chem. 2023 Nov 7. doi: 10.1021/acs.jmedchem.3c01669.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: